Long noncoding RNA SNHG12 is a potential diagnostic and prognostic biomarker in various tumors.

ABSTRACT:

Background

Tumors are the second most common cause of death in humans worldwide, second only to cardiovascular and cerebrovascular diseases. Although methods and techniques for the treatment of tumors continue to improve, the effect is not satisfactory. These may lack effective therapeutic targets. This study aimed to evaluate the value of SNHG12 as a biomarker in the prognosis and clinical characteristics of various cancer patients.

Methods

We analyzed SNHG12 expression and plotted the survival curves of all cancer samples in the TCGA database using the GEPIA tool. Then, we searched for eligible papers up to April 1, 2019, in databases. Next, the data were extracted from studies examining SNHG12 expression, overall survival and clinicopathological features in patients with

SUBMITTER: Wang X 

PROVIDER: S-EPMC8351140 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature